UPDATE 1-EU agency backs approval of new GlaxoSmithKline melanoma drug
April 25, 2014 at 11:19 AM EDT
LONDON, April 25 (Reuters) - GlaxoSmithKline's melanoma drug Mekinist - one of several drugs being sold to Novartis under an asset swap deal - has been recommended for approval by European regulators.
